Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Bamba Gaye

AfOx Fellow 2024

Prof. Dr Bamba Gaye, MD, PhD is a Research Scientist in Preventive Cardiology at the Institute of Health and Development (ISED), Faculty of Medicine, Pharmacy and Odontology, University Cheikh Anta Diop of Dakar, Senegal and as an Adjunct Professor of Biomedical Informatics at Emory School of Medicine in Atlanta, Georgia, USA. He is currently a visiting fellow at the Nuffield Department of Population Health, University of Oxford, working in collaboration with Dr Jennifer Carter through the Africa Oxford Initiative (AfOx) Visiting Fellowship programme.

Dr Gaye’s research centers on congenital heart diseases, with a particular focus on the epidemiology of bicuspid aortic valve (BAV) and its related aortopathies in Sub-Saharan Africa. His current project, “Epidemiology of Congenital Bicuspid Aortic Valve and Associated Aortopathy in Sub-Saharan African Countries (BAVSSA),” aims to fill a critical gap in data on congenital cardiac anomalies across Senegal, The Gambia, and Uganda.

The study seeks to establish the first nationally representative BAV cohort in the region, assess disease prevalence, associated complications, and investigate genetic and environmental risk factors through detailed clinical, familial, and biochemical analyses. This work also establishes a longitudinal blood-based cohort for future follow-up studies.

Dr Gaye’s research addresses a major knowledge gap in cardiovascular health in low-resource settings, aiming to improve early diagnosis, clinical outcomes, and policy guidance for congenital heart disease across Sub-Saharan Africa and other low- and middle-income countries.